- Home
- SHOO vs OCUL Comparison
SHOO vs OCUL Comparison
Compare SHOO & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHOO
- OCUL
- Stock Information
- Founded
- SHOO 1990
- OCUL 2006
- Country
- SHOO United States
- OCUL United States
- Employees
- SHOO N/A
- OCUL N/A
- Industry
- SHOO Shoe Manufacturing
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- SHOO Consumer Discretionary
- OCUL Health Care
- Exchange
- SHOO Nasdaq
- OCUL Nasdaq
- Market Cap
- SHOO 2.0B
- OCUL 1.8B
- IPO Year
- SHOO 1993
- OCUL 2014
- Fundamental
- Price
- SHOO $30.32
- OCUL $13.60
- Analyst Decision
- SHOO Hold
- OCUL Strong Buy
- Analyst Count
- SHOO 7
- OCUL 6
- Target Price
- SHOO $27.83
- OCUL $17.20
- AVG Volume (30 Days)
- SHOO 1.3M
- OCUL 2.2M
- Earning Date
- SHOO 07-30-2025
- OCUL 08-05-2025
- Dividend Yield
- SHOO 2.79%
- OCUL N/A
- EPS Growth
- SHOO N/A
- OCUL N/A
- EPS
- SHOO 1.28
- OCUL N/A
- Revenue
- SHOO $2,319,527,000.00
- OCUL $56,664,000.00
- Revenue This Year
- SHOO $11.61
- OCUL N/A
- Revenue Next Year
- SHOO $10.13
- OCUL $18.87
- P/E Ratio
- SHOO $23.61
- OCUL N/A
- Revenue Growth
- SHOO 7.97
- OCUL N/A
- 52 Week Low
- SHOO $19.05
- OCUL $5.79
- 52 Week High
- SHOO $50.01
- OCUL $13.82
- Technical
- Relative Strength Index (RSI)
- SHOO 67.97
- OCUL 68.16
- Support Level
- SHOO $28.91
- OCUL $12.41
- Resistance Level
- SHOO $29.77
- OCUL $12.49
- Average True Range (ATR)
- SHOO 0.99
- OCUL 0.56
- MACD
- SHOO 0.22
- OCUL 0.04
- Stochastic Oscillator
- SHOO 88.77
- OCUL 88.48
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.